K. Tsuta

1.1k total citations
23 papers, 779 citations indexed

About

K. Tsuta is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, K. Tsuta has authored 23 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in K. Tsuta's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). K. Tsuta is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). K. Tsuta collaborates with scholars based in Japan, United States and United Kingdom. K. Tsuta's co-authors include Hisao Asamura, Ryoji Kushima, Takashi Kohno, Koh Furuta, Akihiko Yoshida, Hitoshi Tsuda, Yoko Shimada, Kanji Nagai, Genichiro Ishii and Yae Kanai and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and British Journal of Cancer.

In The Last Decade

K. Tsuta

20 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Tsuta Japan 14 382 314 258 161 148 23 779
Stefano Sioletic Italy 14 282 0.7× 241 0.8× 214 0.8× 99 0.6× 110 0.7× 27 719
Philip T. Cagle United States 10 352 0.9× 332 1.1× 287 1.1× 113 0.7× 212 1.4× 12 828
Bin Meng China 18 186 0.5× 334 1.1× 245 0.9× 152 0.9× 141 1.0× 62 814
Hideyuki Abe Japan 20 351 0.9× 416 1.3× 294 1.1× 175 1.1× 213 1.4× 63 907
Lucia Nappi Canada 13 240 0.6× 153 0.5× 405 1.6× 191 1.2× 186 1.3× 78 734
Masao Hori Japan 14 129 0.3× 241 0.8× 244 0.9× 217 1.3× 85 0.6× 43 686
D. Skarlos Greece 17 284 0.7× 484 1.5× 172 0.7× 155 1.0× 53 0.4× 51 743
Tilmann Lantzsch Germany 14 101 0.3× 294 0.9× 237 0.9× 172 1.1× 209 1.4× 26 819
Mitsuru Miyachi Japan 15 297 0.8× 207 0.7× 397 1.5× 79 0.5× 251 1.7× 51 762
Laury Finn United States 13 302 0.8× 241 0.8× 164 0.6× 282 1.8× 123 0.8× 22 671

Countries citing papers authored by K. Tsuta

Since Specialization
Citations

This map shows the geographic impact of K. Tsuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Tsuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Tsuta more than expected).

Fields of papers citing papers by K. Tsuta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Tsuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Tsuta. The network helps show where K. Tsuta may publish in the future.

Co-authorship network of co-authors of K. Tsuta

This figure shows the co-authorship network connecting the top 25 collaborators of K. Tsuta. A scholar is included among the top collaborators of K. Tsuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Tsuta. K. Tsuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Motoi, Noriko, Genichiro Ishii, Yuichiro Hayashi, et al.. (2018). OA03.02 Nationwide Comparative Study Of PD-L1 IHC Assays on Lung Cancer: Initial Report Of LC-SCRUM-IBIS Project. Journal of Thoracic Oncology. 13(10). S324–S325. 1 indexed citations
2.
Matsumoto, Shingo, Kiyotaka Yoh, Kadoaki Ohashi, et al.. (2016). Detectability of druggable gene fusions by amplicon-based next generation sequencing in nationwide lung cancer genomic screening project (LC-SCRUM-Japan). Annals of Oncology. 27. vi420–vi420.
3.
Iwakawa, Reika, Takashi Kohno, Yasushi Totoki, et al.. (2015). Expression and clinical significance of genes frequently mutated in small cell lung cancers defined by whole exome/RNA sequencing. Carcinogenesis. 36(6). 616–621. 64 indexed citations
4.
Mizugaki, Hidenori, Yutaka Fujiwara, Noboru Yamamoto, et al.. (2014). Adjuvant Chemotherapy in Patients with Completely Resected Small Cell Lung Cancer: A Retrospective Analysis of 26 Consecutive Cases. Japanese Journal of Clinical Oncology. 44(9). 835–840.
5.
Tsuta, K., Takashi Kohno, Akihiko Yoshida, et al.. (2014). RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis. British Journal of Cancer. 110(6). 1571–1578. 134 indexed citations
6.
Yagishita, Shigehiro, Hidehito Horinouchi, Tomoko Yorozu, et al.. (2013). Secondary Osteosarcoma Developing 10 Years after Chemoradiotherapy for Non-small-cell Lung Cancer. Japanese Journal of Clinical Oncology. 44(2). 191–194. 1 indexed citations
7.
Tsuta, K., Kouya Shiraishi, Takuro Mizukami, et al.. (2013). Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations. Annals of Oncology. 25(1). 138–142. 101 indexed citations
8.
Maeshima, Arafumi, Naobumi Tochigi, K. Tsuta, et al.. (2013). Prognostic Impact of Pleural Invasion in 1488 Patients with Surgically Resected Non-small Cell Lung Carcinoma. Japanese Journal of Clinical Oncology. 43(5). 540–546. 23 indexed citations
9.
Nishikawa, Gen, Shigeki Sekine, Reiko Ogawa, et al.. (2013). Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms. British Journal of Cancer. 108(4). 951–958. 129 indexed citations
10.
Noro, Rintaro, Kazufumi Honda, K. Tsuta, et al.. (2013). Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification. Annals of Oncology. 24(10). 2594–2600. 33 indexed citations
11.
Miyanaga, Akihiko, Kazufumi Honda, K. Tsuta, et al.. (2012). Diagnostic and prognostic significance of the alternatively spliced ACTN4 variant in high-grade neuroendocrine pulmonary tumours. Annals of Oncology. 24(1). 84–90. 25 indexed citations
12.
Mimae, Takahiro, K. Tsuta, Tadashi Kondo, et al.. (2012). Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. Annals of Oncology. 23(12). 3129–3137. 14 indexed citations
13.
Furugen, Makoto, Ikuo Sekine, K. Tsuta, et al.. (2011). Combination Chemotherapy with Carboplatin and Paclitaxel for Advanced Thymic Cancer. Japanese Journal of Clinical Oncology. 41(8). 1013–1016. 31 indexed citations
14.
Shibata, Toshiyuki, Akiko Kokubu, Manabu Miyamoto, et al.. (2010). DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung. Oncogene. 29(33). 4671–4681. 54 indexed citations
15.
Suzuki, Kenji, K. Tsuta, Masahiko Kusumoto, et al.. (2007). Molecular Markers and Changes of Computed Tomography Appearance in Lung Adenocarcinoma with Ground-glass Opacity. Japanese Journal of Clinical Oncology. 37(12). 907–912. 20 indexed citations
16.
Fujiwara, Yutaka, Ikuo Sekine, K. Tsuta, et al.. (2007). Effect of Platinum Combined with Irinotecan or Paclitaxel against Large Cell Neuroendocrine Carcinoma of the Lung. Japanese Journal of Clinical Oncology. 37(7). 482–486. 34 indexed citations
17.
Shiono, Satoshi, Genichiro Ishii, Kanji Nagai, et al.. (2006). Immunohistochemical prognostic factors in resected colorectal lung metastases using tissue microarray analysis. European Journal of Surgical Oncology. 32(3). 308–309. 23 indexed citations
19.
Yonemori, Keiichi, K. Tsuta, Ukihide Tateishi, et al.. (2006). Diagnostic accuracy of CT-guided percutaneous cutting needle biopsy for thymic tumours. Clinical Radiology. 61(9). 771–775. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026